Kalendis Martiis 12th 2022, NMPA (SFDA) denuntiavit approbans mutationem applicationis ad sui experimentum COVID-19 antigenarum productorum Nanjing Vazyme Biotech Co, Ltd, Beijing Jinwofu Bioengineering Technologiae Co, Ltd, Shenzhen Huada Yinyuan Pharmaceutical. Technologia Co., Ltd, Guangzhou Wondfo B...
Lege plus